Rosella Centis Selected Research

Extensively Drug-Resistant Tuberculosis

3/2022	Drug resistant TB - latest developments in epidemiology, diagnostics and management.
1/2019	Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.
1/2018	Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
10/2017	Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
7/2017	Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.
6/2017	Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis.
5/2017	Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
3/2017	Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.
3/2017	Classifying new anti-tuberculosis drugs: rationale and future perspectives.
2/2017	Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosella Centis Research Topics

Disease

34	Extensively Drug-Resistant Tuberculosis 03/2022 - 10/2007
24	Tuberculosis (Tuberculoses) 01/2022 - 11/2008
23	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2022 - 05/2010
4	Coinfection 03/2015 - 09/2013
2	Pulmonary Tuberculosis 01/2019 - 01/2018
2	Lung Diseases (Lung Disease) 03/2016 - 05/2010
1	Infections 02/2022
1	COVID-19 01/2022
1	Asthma (Bronchial Asthma) 12/2020
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 10/2017
1	Thrombocytopenia (Thrombopenia) 06/2017
1	Hypothyroidism 05/2017
1	Body Weight (Weight, Body) 01/2017
1	Tuberculoma 07/2016
1	Pleural Empyema (Pyothorax) 07/2016
1	Noncommunicable Diseases 10/2015
1	HIV Infections (HIV Infection) 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2012

Drug/Important Bio-Agent (IBA)

31	Pharmaceutical PreparationsIBA 03/2022 - 10/2007
18	bedaquiline (R207910)IBA 03/2022 - 01/2014
16	OPC-67683IBA 03/2022 - 09/2014
9	Linezolid (Zyvox)FDA Link 03/2022 - 10/2009
7	Rifampin (Rifampicin)FDA LinkGeneric 03/2022 - 09/2010
6	FluoroquinolonesIBA 03/2022 - 10/2012
6	Meropenem (Merrem)FDA LinkGeneric 01/2018 - 06/2013
5	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 06/2013
4	Isoniazid (Ftivazide)FDA LinkGeneric 03/2022 - 09/2010
4	Clofazimine (Lamprene)FDA Link 01/2018 - 11/2016
3	Imipenem FDA Link 05/2016 - 01/2016
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2018 - 03/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 01/2016
2	Ertapenem (Invanz)FDA Link 03/2016 - 01/2016
2	VaccinesIBA 10/2015 - 03/2015
1	BCG Vaccine FDA Link 02/2022
1	AntigensIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 03/2020
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Oxygen (Dioxygen)IBA 09/2016
1	GasesIBA 09/2016
1	Volatile Organic CompoundsIBA 10/2015
1	Nucleic AcidsIBA 10/2015
1	pretomanidIBA 05/2015
1	Gatifloxacin (Zymar)FDA Link 03/2015
1	Moxifloxacin (Avelox)FDA Link 03/2015
1	SolutionsIBA 01/2015

Therapy/Procedure

4	Therapeutics 12/2020 - 03/2015
4	Duration of Therapy 01/2018 - 07/2013
3	Drug Therapy (Chemotherapy) 03/2022 - 07/2016
1	Combined Modality Therapy 12/2020
1	Continuity of Patient Care 11/2020
1	Art Therapy 01/2015
1	Injections 07/2013